title: Immune mechanisms associated with the rejection of fetal murine proislet allografts and pig proislet xenografts: comparison of intragraft cytokine mRNA profiles.
abstract: BACKGROUND
  Previous in vivo depletion studies of CD4 and CD8 T cells indicated that different rejection mechanisms operate for proislet allografts and xenografts. The cellular and molecular mechanisms of acute proislet allograft and xenograft rejection have therefore been characterized and directly compared.
  
  
  METHODS
  The intragraft cytokine mRNA profile in rejecting BALB/c (H-2d) proislet allografts was analyzed in control, CD4 T cell-depleted, and CD8 T cell-depleted CBA/H (H-2k) recipient mice using semi-quantitative reverse transcriptase-assisted polymerase chain reaction (RT-PCR). The cytokine profiles for proislet allografts and pig proislet xenografts at 3-10 days posttransplant were directly compared and correlated with graft histopathology.
  
  
  RESULTS
  Allograft rejection was protracted (2-3 weeks), characterized by infiltrating CD8 T cells and CD4 T cells (no eosinophils) and was associated with a Th1-type CD4 T cell response (IL-2, IFN-gamma, and IL-3 mRNA) and a CD8 T cell-dependent spectrum of cytokine gene expression (IL-2, IFN-gamma, IL-3, and IL-10 mRNA). Xenograft rejection was rapid (6-8 days), involved predominantly CD4 T cells and eosinophils, and in contrast to allografts, exhibited intragraft mRNA expression for the Th2 cytokines IL-4 and IL-5.
  
  
  CONCLUSIONS
  Proislet allograft and xenograft rejection differ in the tempo of destruction, phenotype of the cellular response and intragraft profile of cytokine mRNA. The recruitment of eosinophils only to the site of xenorejection correlates with IL4 and IL-5 mRNA expression. These findings suggest that different anti-rejection strategies may need to be developed to optimally target the allograft and the xenograft response.
authors.affiliation: Division of Molecular Medicine, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT.
authors.forename: C J
authors.initials: CJ
authors.lastname: Simeonovic
authors.forename: M J
authors.initials: MJ
authors.lastname: Townsend
authors.forename: C F
authors.initials: CF
authors.lastname: Morris
authors.forename: A J
authors.initials: AJ
authors.lastname: Hapel
authors.forename: M C
authors.initials: MC
authors.lastname: Fung
authors.forename: D A
authors.initials: DA
authors.lastname: Mann
authors.forename: I G
authors.initials: IG
authors.lastname: Young
authors.forename: J D
authors.initials: JD
authors.lastname: Wilson
mesh_terms: D000818:Animals; D016207:Cytokines / Q000235:genetics; D016332:Fetal Tissue Transplantation / Q000276:immunology*; D005333:Fetus / Q000033:anatomy & histology / Q000378:metabolism; D006084:Graft Rejection / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D007150:Immunohistochemistry; D007515:Islets of Langerhans / Q000196:embryology* / Q000378:metabolism / Q000473:pathology; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D012333:RNA, Messenger / Q000378:metabolism; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D016207:Cytokines; D012333:RNA, Messenger